HIV molecular immunology database

 

Search Antibody Database

Found 1 matching record:

Displaying record number 720

Download this epitope record as JSON.

MAb ID polyclonal
HXB2 Location gp160(305-322)
DNA(7137..7190)
gp160 Epitope Map
Author Location gp140( SF162)
Epitope KSITIGPGRAFYATGD Epitope Alignment
KSITIGPGRAFYATGD epitope logo
Ab Type gp120 V3 // V3 glycan (V3g)
Neutralizing  
Species (Isotype) macaque, rabbit(IgG)
Patient  
Immunogen vaccine
Keywords  

Vaccine Details

Vaccine type DNA with CMV promotor
Vaccine strain B clade SF162
Vaccine component gp140
Adjuvant MF59

Notes

Showing 1 of 1 note.

References

Showing 1 of 1 reference.

Barnett2001a S. W. Barnett, S. Lu, I. Srivastava, S. Cherpelis, A. Gettie, J. Blanchard, S. Wang, I. Mboudjeka, L. Leung, Y. Lian, A. Fong, C. Buckner, A. Ly, S. Hilt, J. Ulmer, C. T. Wild, J. R. Mascola, and L. Stamatatos. The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region. J. Virol., 75(12):5526--40, Jun 2001. URL: http://jvi.asm.org/cgi/content/full/75/12/5526. PubMed ID: 11356960. Show all entries for this paper.


Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy’s National Nuclear Security Administration
Copyright © 2022 Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health